Skip to main content
Premium Trial:

Request an Annual Quote

Timothy Kennedy

Biocept has appointed Timothy Kennedy as CFO and senior vice president of operations. He succeeds Mark Foletta, who has served as interim CFO since August 2015 and will remain a consultant to the company beginning in September 2016. Kennedy comes to Biocept from Millennium Health, where he served as CFO from 2013 to July 2016. Before his time at Millennium Health, Kennedy served as CFO and general manager of PLUS Diagnostics from 2008 to 2012.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.